NCT00296504 - A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects | Biotech Hunter

Enrollment

753

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

fosamprenavir (GW433908)

DRUG

ritonavir

Trial Locations (24)

6080

GSK Investigational Site, Badajoz

11030

GSK Investigational Site, Manhasset

13005

GSK Investigational Site, Marseille

16128

GSK Investigational Site, Genoa

32804

GSK Investigational Site, Orlando

32806

GSK Investigational Site, Orlando

33145

GSK Investigational Site, Fort Lauderdale

33614

GSK Investigational Site, Tampa

34239

GSK Investigational Site, Sarasota

54511

GSK Investigational Site, Vandœuvre-lès-Nancy

75475

GSK Investigational Site, Paris

75970

GSK Investigational Site, Paris

80262

GSK Investigational Site, Denver

92708

GSK Investigational Site, Fountain Valley

94275

GSK Investigational Site, Le Kremlin-Bicêtre

94805

GSK Investigational Site, Villejuif

13083970

GSK Investigational Site, Campinas

94115-1931

GSK Investigational Site, San Francisco

77555-1188

GSK Investigational Site, Galveston

Unknown

GSK Investigational Site, Santiago

3000-075

GSK Investigational Site, Coimbra

08036

GSK Investigational Site, Barcelona

NW3 2QG

GSK Investigational Site, London

SE1 7EH

GSK Investigational Site, London